PSTTF
Price:
$0.145
Market Cap:
$71.50M
Operating from Melbourne, Australia, Prescient Therapeutics Limited is a clinical-stage oncology company dedicated to pioneering novel pharmaceutical treatments for a variety of cancers. The company's primary investigational therapy, PTX-200, is currently undergoing several advanced clinical trials: a Phase 2a study for HER2-negative breast cancer, a Phase 1B/2 trial addressing relapsed and refractory acute myeloid leukemia (AML), and a Phase 1b trial for platinum-resistant ovarian cancer that has recurred or persisted. Another key pipeline asset is PTX-100, a RhoA inhibitor, engineered to combat both blood and solid tumors, particularly those characterized by specific Ras and RhoA genetic m...[Read more]
Industry
Biotechnology
IPO Date
2017-09-13
Stock Exchange
OTC
Ticker
PSTTF
According to Prescient Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 62.23M. This represents a change of 56.37% compared to the average of 39.80M of the last 4 quarters.
The mean historical Enterprise Value of Prescient Therapeutics Limited over the last ten years is 35.84M. The current 62.23M Enterprise Value has changed 17.26% with respect to the historical average. Over the past ten years (40 quarters), PSTTF's Enterprise Value was at its highest in in the June 2021 quarter at 141.13M. The Enterprise Value was at its lowest in in the June 2016 quarter at -1038705.66.
Average
35.84M
Median
20.00M
Minimum
-2522136.75
Maximum
133.96M
Discovering the peaks and valleys of Prescient Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 850.76%
Maximum Annual Enterprise Value = 133.96M
Minimum Annual Increase = -13862.08%
Minimum Annual Enterprise Value = -2522136.75
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 28.50M | 29.25% |
| 2024 | 22.05M | -58.42% |
| 2023 | 53.03M | -39.83% |
| 2022 | 88.15M | -34.20% |
| 2021 | 133.96M | 850.76% |
| 2020 | 14.09M | -13862.08% |
| 2019 | -102382.00 | -100.57% |
| 2018 | 17.95M | 438.47% |
| 2017 | 3.33M | -232.18% |
| 2016 | -2522136.75 | -217.50% |
The current Enterprise Value of Prescient Therapeutics Limited (PSTTF) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
34.53M
5-year avg
65.14M
10-year avg
35.84M
Prescient Therapeutics Limited’s Enterprise Value is less than Eupraxia Pharmaceuticals Inc. (160.81M), less than AnGes, Inc. (17.66B), less than Adocia S.A. (75.41M), less than Ascentage Pharma Group International (10.57B), less than Mind Cure Health Inc. (112.12M), less than Anteris Technologies Ltd (331.09M), less than China Medical & HealthCare Group Limited (1.01B), less than Leafly Holdings, Inc. (132.00M), less than Japan Medical Dynamic Marketing, Inc. (23.87B), greater than Cell MedX Corp. (7.33M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 160.81M | $108.29M | |
| 17.66B | $142.50M | |
| 75.41M | $103.66M | |
| 10.57B | $127.31M | |
| 112.12M | $86.53M | |
| 331.09M | $120.50M | |
| 1.01B | $123.01M | |
| 132.00M | $114.90M | |
| 23.87B | $156.35M | |
| 7.33M | $126.33M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prescient Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Prescient Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Prescient Therapeutics Limited's Enterprise Value?
What is the highest Enterprise Value for Prescient Therapeutics Limited (PSTTF)?
What is the 3-year average Enterprise Value for Prescient Therapeutics Limited (PSTTF)?
What is the 5-year average Enterprise Value for Prescient Therapeutics Limited (PSTTF)?
How does the current Enterprise Value for Prescient Therapeutics Limited (PSTTF) compare to its historical average?